<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04910607</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2020/38</org_study_id>
    <nct_id>NCT04910607</nct_id>
  </id_info>
  <brief_title>Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.</brief_title>
  <acronym>OBIMPACOV</acronym>
  <official_title>Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Région Nouvelle Aquitaine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The population suffering from obesity is particularly at risk during this pandemic period.&#xD;
      The Nouvelle Aquitaine region is not spared, since according to the regional epidemiological&#xD;
      report of 7 May 2020, carried out by Santé Publique France, 39.2% of cases admitted to the&#xD;
      intensive care unit in Nouvelle Aquitaine and presenting risk factors are overweight or&#xD;
      obese.&#xD;
&#xD;
      Other risk factors, such as social-environmental factors, must be taken into consideration.&#xD;
      Socio-demographic surveys in this area highlight the socio-economic and territorial&#xD;
      inequalities that interfere with obesity issues. Similarly, the issues of stigmatisation and&#xD;
      isolation seem to be at the heart of the question of how to deal with these people.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective multicentre study. Participating patients will be recruited from the&#xD;
      Specialised Obesity Centres (CHU and SSR, as well as patient associations) to fill in a&#xD;
      questionnaire and take part in an interview (a varied panel representative of the target&#xD;
      population in terms of place of residence, socio-professional category, sex and age).&#xD;
&#xD;
      The medical and paramedical staff involved in the partner CSOs and the patients' resources&#xD;
      (identified by the patients' associations) will also be asked to participate in a&#xD;
      semi-directive interview.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analysed social and psychological impacts of containment</measure>
    <time_frame>9 months after inclusion day</time_frame>
    <description>Thanks to sociology questionnaire based on the experience and paths of individuals (not a score).&#xD;
The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Consequences of social distancing during the containment</measure>
    <time_frame>9 months after inclusion day</time_frame>
    <description>Thanks to sociology questionnaire based on the experience and paths of individuals(not a score).&#xD;
The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Obesity</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <description>Participating patients will be recruited from the Specialised Obesity Centres =CSO (CHU and Follow-up and rehabilitation care (SSR), as well as patient associations) to fill in a questionnaire and take part in an interview (varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Professional</arm_group_label>
    <description>Medical and paramedical staff involved in the partner CSOs will also be asked to participate in a semi-structured interview.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Questionnaire with 4 axes:&#xD;
sociological, reflexive medical, prospective medical, transversal</description>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interview</intervention_name>
    <description>Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.</description>
    <arm_group_label>Patient</arm_group_label>
    <arm_group_label>Professional</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The obese population is the target population of the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years of age.&#xD;
&#xD;
          -  Be registered in an active file of the 3 partner CSOs.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18 years of age.&#xD;
&#xD;
          -  Patients under protective measures or deprived of liberty:&#xD;
&#xD;
               -  pregnant or breastfeeding woman,&#xD;
&#xD;
               -  under guardianship,&#xD;
&#xD;
               -  under guardianship,&#xD;
&#xD;
               -  safeguard of justice,&#xD;
&#xD;
               -  incarcerated.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud ALESSANDRIN, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Universite de Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Blandine GATTA-CHERIFI, Pr</last_name>
    <phone>5 57 65 60 78</phone>
    <phone_ext>+33</phone_ext>
    <email>blandine.gatta-cherifi@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maud MONSAINGEON-HENRY, Dr</last_name>
    <phone>5 57 62 32 07</phone>
    <phone_ext>+33</phone_ext>
    <email>maud.monsaingeon-henry@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Pierre JESUS, Pr</last_name>
      <email>pierre.jesus@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitam Haut-Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Blandine GATTA-CHERIFI, Pr</last_name>
      <phone>5 57 65 60 78</phone>
      <phone_ext>+33</phone_ext>
      <email>blandine.gatta-cherifi@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Xavier PIGUEL, Dr</last_name>
      <email>Xavier.PIGUEL@chu-poitiers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>June 9, 2021</last_update_submitted>
  <last_update_submitted_qc>June 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>COVID19</keyword>
  <keyword>semi-directive interview</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

